| Financial Year |
March 31 2023 |
| Monetary Funds |
1,777,881,171.63 |
| Held-for-trading Financial Assets |
526,844,697.25 |
| Notes Receivable |
-- |
| Accounts Receivable |
430,070,163.13 |
| Advances to Suppliers |
22,538,749.76 |
| Other Receivables |
5,384,707.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,487,506,220.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,417,439.07 |
| Total Current Assets |
8,435,823,631.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,325,072,286.58 |
| Investment Properties |
61,626,849.07 |
| Fixed Assetes |
3,660,881,715.96 |
| Under-construction Projects |
429,236,155.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
643,732,967.65 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
60,507,906.01 |
| Other Non-Current Assets |
97,453,572.09 |
| Sub-Total of Non-Current Assets |
7,479,375,854.58 |
| Total Assets |
15,915,199,485.58 |
| Short-Term Loans |
2,703,592,211.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
187,810,161.74 |
| Accounts Received In Advance |
74,126.78 |
| Employee Compensation Payable |
63,724,453.79 |
| Taxes Payable |
49,927,928.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,862,374.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
442,021,769.38 |
| Other Current Liabilities |
87,008,396.27 |
| Sub-Total of Current Liabilities |
3,637,846,674.12 |
| Long-term Loans |
2,055,080,923.12 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
30,830,925.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,248,730,347.00 |
| Total Liabilities |
5,886,577,021.12 |
| Paid-In Capital(Or Share Stock) |
1,500,000,000.00 |
| Capital Surplus |
2,371,294,331.31 |
| Surplus Reserve |
528,410,855.45 |
| LESS:Treasury Stock |
68,729,009.10 |
| Undistributed Profits |
5,600,777,446.37 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,028,622,464.46 |
| Owner's Equity（Stockholder's Equity） |
10,028,622,464.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,915,199,485.58 |
